DarioHealth Capital Surpluse from 2010 to 2024

DRIO Stock  USD 0.97  0.08  8.99%   
DarioHealth Corp Capital Surpluse yearly trend continues to be very stable with very little volatility. Capital Surpluse is likely to grow to about 441.8 M this year. During the period from 2010 to 2024, DarioHealth Corp Capital Surpluse quarterly data regression pattern had sample variance of 24491.9 T and median of  74,892,000. View All Fundamentals
 
Capital Surpluse  
First Reported
2013-12-31
Previous Quarter
370.7 M
Current Value
395.4 M
Quarterly Volatility
123.9 M
 
Yuan Drop
 
Covid
Check DarioHealth Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DarioHealth Corp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.5 M, Interest Expense of 0.0 or Selling General Administrative of 9.6 M, as well as many indicators such as Price To Sales Ratio of 2.28, Dividend Yield of 0.0 or PTB Ratio of 0.71. DarioHealth financial statements analysis is a perfect complement when working with DarioHealth Corp Valuation or Volatility modules.
  
Check out the analysis of DarioHealth Corp Correlation against competitors.
To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.

Latest DarioHealth Corp's Capital Surpluse Growth Pattern

Below is the plot of the Capital Surpluse of DarioHealth Corp over the last few years. It is DarioHealth Corp's Capital Surpluse historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in DarioHealth Corp's overall financial position and show how it may be relating to other accounts over time.
Capital Surpluse10 Years Trend
Slightly volatile
   Capital Surpluse   
       Timeline  

DarioHealth Capital Surpluse Regression Statistics

Arithmetic Mean147,332,946
Geometric Mean79,703,051
Coefficient Of Variation106.22
Mean Deviation129,416,428
Median74,892,000
Standard Deviation156,499,006
Sample Variance24491.9T
Range421.8M
R-Value0.91
Mean Square Error4692.1T
R-Squared0.82
Slope31,729,285
Total Sum of Squares342887.1T

DarioHealth Capital Surpluse History

2024441.8 M
2023420.7 M
2022365.8 M
2021307.6 M
2020171.4 M
2019129 M
201898.2 M

About DarioHealth Corp Financial Statements

DarioHealth Corp investors utilize fundamental indicators, such as Capital Surpluse, to predict how DarioHealth Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Capital Surpluse420.7 M441.8 M

Pair Trading with DarioHealth Corp

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DarioHealth Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DarioHealth Corp will appreciate offsetting losses from the drop in the long position's value.

Moving against DarioHealth Stock

  0.49EHAB EnhabitPairCorr
  0.47GH Guardant Health Buyout TrendPairCorr
  0.47LH LaboratoryPairCorr
  0.46EDAP EDAP TMS SAPairCorr
  0.32VTAK Catheter PrecisionPairCorr
The ability to find closely correlated positions to DarioHealth Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DarioHealth Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DarioHealth Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DarioHealth Corp to buy it.
The correlation of DarioHealth Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DarioHealth Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DarioHealth Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DarioHealth Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether DarioHealth Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DarioHealth Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dariohealth Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dariohealth Corp Stock:
Check out the analysis of DarioHealth Corp Correlation against competitors.
To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DarioHealth Corp. If investors know DarioHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DarioHealth Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.18)
Revenue Per Share
0.575
Quarterly Revenue Growth
0.017
Return On Assets
(0.33)
Return On Equity
(0.69)
The market value of DarioHealth Corp is measured differently than its book value, which is the value of DarioHealth that is recorded on the company's balance sheet. Investors also form their own opinion of DarioHealth Corp's value that differs from its market value or its book value, called intrinsic value, which is DarioHealth Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DarioHealth Corp's market value can be influenced by many factors that don't directly affect DarioHealth Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DarioHealth Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if DarioHealth Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DarioHealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.